Furamags®

Furamags®

Active substance: Furaginum solubile

Indications: Acute and relapsing infections of urinary tract; prostatitis and gynaecological infections; prevention in the event of urological surgeries, cystoscopy and catheterisation

Dose and quantity: 25 mg N30; 50 mg N30

Pharmaceutical form: hard capsules

ATC Code: J01XE

Antibacterial agent belonging to nitrofuran group.

 

Furamag® is efficient against the most common agents of urinary tract infection, for instance, E.Coli.

No clinically significant antimicrobial resistance develops as a result of the use of Furamag®.

Use int eh event of therapy:

In adults:

50 – 100 mg three times per day after meals.

In children with the body mass of more than 30 kg:

50 mg three times per day after meals.

In 1 to 10 year-old children:

5 mg/kg per day, by dividing the daily dose into 2-3 administrations per day after meals. For more detailed instructions of medicinal product use, see the summary of product characteristics.

The duration of the therapy course is 7 – 10 days

For preventive use:

In adults and children with the body mass of more than 30 kg:

50 mg before going to bed.

In 1 to 10 year-old children:

1 – 2 mg/kg per day after meals.

 

Advertising intended for specialists only.

Summary of Product Characteristics

The advertiser: AS Olainfarm, Olaine, Rūpnīcu iela 5, LV-2114. Material prepared: February 2020.

 CAREFULLY READ THE INSTRUCTIONS OR OTHER APPROPRIATE INFORMATION ON PACKAGING. CONSULT YOUR DOCTOR OR PHARMACIST ABOUT THE USE OF MEDICINES.

UNJUSTIFIED USE OF MEDICINES IS HARMFUL FOR HEALTH